Modulation of Cell Surface Expression of Nonactivated Cholecystokinin Receptors Using Bivalent Ligand-Induced Internalization

Journal of Medicinal Chemistry
2010.0

Abstract

CCK(2) receptor antagonists potentiate pain relief by MOP receptor agonists. In an attempt to enhance this effect, we prepared bivalent ligands incorporating CCK(2) receptor antagonist and MOP receptor agonist pharmacophores. (9) Ligands with 16- to 22-atom spacers could simultaneously bind both receptors but provided no advantage in activity over individual ligands. We now examine the effect of these ligands on receptor internalization as a mechanism of receptor regulation. We prepared CHO cell lines expressing nonfluorescent halves (YN and YC) of yellow fluorescent protein attached to each receptor. Spatial approximation of constructs was needed to yield fluorescence. Monovalent MOP agonist 1 signaled normally and internalized the MOP receptor. Monovalent CCK(2) antagonist 2 did not stimulate receptor internalization. In the dual receptor-bearing cells, bivalent ligands 3a-c capable of simultaneously binding both receptors resulted in cell surface fluorescence and internalization of the fluorescent complex in a time- and temperature-dependent manner. Bivalent ligand 4 with spacer too short to occupy both receptors simultaneously yielded no signal. Receptor tethering with appropriate bivalent ligands can down-regulate signaling by moving a nonactivated receptor into the endocytic pathway.

Knowledge Graph

Similar Paper

Modulation of Cell Surface Expression of Nonactivated Cholecystokinin Receptors Using Bivalent Ligand-Induced Internalization
Journal of Medicinal Chemistry 2010.0
Induced Association of μ Opioid (MOP) and Type 2 Cholecystokinin (CCK<sub>2</sub>) Receptors by Novel Bivalent Ligands
Journal of Medicinal Chemistry 2009.0
Novel Bivalent Ligands for D2/D3 Dopamine Receptors: Significant Cooperative Gain in D2 Affinity and Potency
ACS Medicinal Chemistry Letters 2012.0
Preparation of bivalent agonists for targeting the mu opioid and cannabinoid receptors
European Journal of Medicinal Chemistry 2019.0
Dualsteric Muscarinic Antagonists–Orthosteric Binding Pose Controls Allosteric Subtype Selectivity
Journal of Medicinal Chemistry 2014.0
Hybrid bivalent ligands with opiate and enkephalin pharmacophores
Journal of Medicinal Chemistry 1987.0
Structure−Activity Relationships of Bifunctional Peptides Based on Overlapping Pharmacophores at Opioid and Cholecystokinin Receptors
Journal of Medicinal Chemistry 2006.0
Design and Characterization of Superpotent Bivalent Ligands Targeting Oxytocin Receptor Dimers via a Channel-Like Structure
Journal of Medicinal Chemistry 2016.0
Bivalent ligand approach on 4-[2-(3-methoxyphenyl)ethyl]-1-(2-methoxyphenyl)piperazine: Synthesis and binding affinities for 5-HT7 and 5-HT1A receptors
Bioorganic &amp; Medicinal Chemistry 2007.0
C-2-Linked Dimeric Strychnine Analogues as Bivalent Ligands Targeting Glycine Receptors
Journal of Natural Products 2021.0